BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12210086)

  • 1. Significance of loss of heterozygosity of the RB1 gene during tumour progression in well-differentiated liposarcomas.
    Schneider-Stock R; Boltze C; Jaeger V; Stumm M; Seiler C; Rys J; Schütze K; Roessner A
    J Pathol; 2002 Aug; 197(5):654-60. PubMed ID: 12210086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
    Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
    J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
    Bièche I; Lidereau R
    Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
    Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
    Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma.
    Choy KW; Pang CP; Yu CB; Wong HL; Ng JS; Fan DS; Lo KW; Chai JT; Wang J; Fu W; Lam DS
    Hum Mutat; 2002 Nov; 20(5):408. PubMed ID: 12402348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches.
    Lahat G; Anaya DA; Wang X; Tuvin D; Lev D; Pollock RE
    Ann Surg Oncol; 2008 Jun; 15(6):1585-93. PubMed ID: 18398663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different mRNA expression profile during tumor progression in a well-differentiated liposarcoma--A microdissection approach.
    Schneider-Stock R; Gerresheim F; Kolin-Gerresheim I; Meyer F; Jäger V; Epplen JT; Roessner A; Boltze C
    Pathol Res Pract; 2003; 199(6):445-50. PubMed ID: 12924448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of well-differentiated/de-differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization.
    Tap WD; Eilber FC; Ginther C; Dry SM; Reese N; Barzan-Smith K; Chen HW; Wu H; Eilber FR; Slamon DJ; Anderson L
    Genes Chromosomes Cancer; 2011 Feb; 50(2):95-112. PubMed ID: 21117066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
    Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
    Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-kit expression in dedifferentiated and well-differentiated liposarcomas; immunohistochemistry and genetic analysis.
    Tayal S; Classen E; Bemis L; Robinson WA
    Anticancer Res; 2005; 25(3B):2215-20. PubMed ID: 16158966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of p53 alterations and Mib-1 proliferation index in subgroups of primary liposarcomas.
    Schneider-Stock R; Ziegeler A; Haeckel C; Franke DS; Rys J; Roessner A
    Clin Cancer Res; 1999 Oct; 5(10):2830-5. PubMed ID: 10537349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
    Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
    Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
    J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas.
    Schneider-Stock R; Walter H; Radig K; Rys J; Bosse A; Kuhnen C; Hoang-Vu C; Roessner A
    J Cancer Res Clin Oncol; 1998; 124(10):532-40. PubMed ID: 9829856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the RB1 gene in dedifferentiated liposarcoma.
    Takahira T; Oda Y; Tamiya S; Yamamoto H; Kobayashi C; Izumi T; Ito K; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2005 Nov; 18(11):1461-70. PubMed ID: 15933756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.
    Snyder EL; Sandstrom DJ; Law K; Fiore C; Sicinska E; Brito J; Bailey D; Fletcher JA; Loda M; Rodig SJ; Dal Cin P; Fletcher CD
    J Pathol; 2009 Jul; 218(3):292-300. PubMed ID: 19449367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.
    Lee SE; Kim YJ; Kwon MJ; Choi DI; Lee J; Cho J; Seo SW; Kim SJ; Shin YK; Choi YL
    Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis.
    Papachristou DJ; Goodman MA; Cieply K; Hunt JL; Rao UN
    Hum Pathol; 2006 Jul; 37(7):890-8. PubMed ID: 16784990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma.
    Hisaoka M; Matsuyama A; Nakamoto M
    Am J Pathol; 2012 May; 180(5):2076-83. PubMed ID: 22429966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.